Würzburg
Universitätsklinikum Würzburg
CAR-T cells against three novel antigens show antitumoral efficacy in ex vivo patient derived glioblastoma organoids
CAR-T cells against three novel antigens show antitumoral efficacy in ex vivo patient derived glioblastoma organoids
A combination of CAR-T cell specificities can overcome antigen escape mechanisms in ex vivo glioblastoma models
Effects of Tumor Treating Fields (TTFields) on glioblastoma, anaplastic ependymoma and oligodendroglioma samples in a patient-derived ex vivo organoid model